NCT02133313View on ClinicalTrials.gov

Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
End Stage Renal Disease
Trial Locations (1)

35294

University of Alabama at Birmingham Home Dialysis Unit (Red Mountain Home Dialysis), Birmingham

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT02133313 - Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis | Biotech Hunter | Biotech Hunter